{
  "type": "hyp",
  "text": "Treatment with 25 mg/kg cyclopamine significantly attenuated VEGF-induced phosphorylation of endogenous substrates whereas 25 mg/kg of cyclopamine decreased this association.\n",
  "self": {
    "NER": {
      "answers": [
        "25 mg/kg",
        "25 mg/kg"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What dose of cyclopamine reduced VEGF-induced phosphorylation of",
          "What dose of cyclopamine reduced VEGF-induced phosphorylation of"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Treatment",
        "25 mg/kg cyclopamine",
        "significantly attenuated VEGF-induced phosphorylation",
        "endogenous substrates",
        "25 mg/kg",
        "cyclopamine",
        "this association"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What significantly attenuated VEGF-induced phosphorylation of endogenous",
          "What treatment significantly reduced VEGF-induced phosphorylation of endogenous substrates",
          "What was the effect of treatment with cyclopamine on endogenous substrates?",
          "What did treatment with cyclopamine reduce?",
          "What dose of cyclopamine reduced VEGF-induced phosphorylation of",
          "What drug reduced VEGF-induced phosphorylation of endogenous substrates?",
          "What did treatment with 25 mg/kg of cyclopamine decrease?"
        ]
      }
    }
  },
  "asked": {
    "What was the effect of cyclopamine on vascular formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.5623182058334351,
        "ground_truth": {
          "2.5": {
            "bertscore": 0.6649394035339355,
            "f1": 0
          }
        }
      }
    },
    "What significantly reduced vascular formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0871272087097168,
        "ground_truth": {
          "Treatment": {
            "bertscore": 0.7012157440185547,
            "f1": 0
          }
        }
      }
    },
    "What treatment significantly reduced vascular formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.05337226390838623,
        "ground_truth": {
          "cyclopamine": {
            "bertscore": 0.6110588312149048,
            "f1": 0
          }
        }
      }
    },
    "What did treatment with cyclopamine significantly attenuate?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "VEGF-induced phosphorylation of endogenous substrates",
        "answerability": 0.9963024854660034,
        "ground_truth": {
          "vascular formation": {
            "bertscore": 0.7243130207061768,
            "f1": 0
          }
        }
      }
    },
    "How much did cyclopamine reduce vascular formation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1560930609703064,
        "ground_truth": {
          "a factor": {
            "bertscore": 0.7014163136482239,
            "f1": 0
          }
        }
      }
    }
  }
}